Full history for every metric is available with a Kvantra account
Surgalign Holdings, Inc. (SRGA)
Key financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 280 | 281 | 117 | 102 | 91 | 82 | 78 |
| Operating profit | $m | -70 | -88 | |||||
| Net profit | $m | 6 | -1 | -249 | -194 | -123 | -55 | -50 |
| EPS reported | $ | -8.33 | -7.78 | |||||
| Operating cashflow per share | $ | -7.95 | -7.95 | |||||
| Capex per share | $ | 1.11 | 1.11 | |||||
| FCF per share | $ | -9.06 | -9.06 | |||||
| Free cash flow | $m | -59 | -49 | |||||
| Net debt | $m | -6 | -12 | |||||
| Book value equity | $m | -26 | -19 | |||||
| Book value per share | $ | -3.92 | -2.89 | |||||
| Number of shares | m | 6.56 | 6.56 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -0.51 | -0.06 | |||||
| P/S LTM | x | 0.16 | 0.02 | |||||
| P/FCF LTM | x | -0.22 | -0.02 | |||||
| EV/EBITDA LTM | x | -0.13 | 0.29 | |||||
| EV/Sales LTM | x | 0.08 | -0.14 | |||||
| Earnings Yield LTM | % | -418.59% | -4554.4% | |||||
| FCF Yield | % | -455.08% | -4106.9% | |||||
| Quality | ||||||||
| ROE | % | 212.23% | 624.34% | |||||
| ROIC | % | -140.78% | -140.78% | |||||
| Operating margin | % | -85.92% | -85.92% | |||||
| Gross margin | % | 49.14% | 49.14% | |||||
| FCF/Sales | % | -72.41% | -72.41% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -9.42% | -11.04% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -5.82 | -4.81 | |||||
| Net Debt/EBITDA | x | 0.12 | 0.12 | |||||
| EBIT/Net interest | x | -69.81 | -69.81 | |||||
| Net debt/market cap | % | -46.78% | -1016.4% | |||||
| Net debt/Equity | x | 0.24 | 0.64 | |||||
| Gross debt/equity | x | -0.40 | -0.54 | |||||
Company overview
Surgalign Holdings, Inc. is a global medical technology firm dedicated to the design, production, distribution, and marketing of spinal implants. Its comprehensive product line addresses various spinal procedures: for thoracolumbar surgeries, it offers systems like the Streamline TL Spinal Fixation for complex and degenerative conditions, and the Streamline MIS Spinal Fixation for minimally invasive approaches, alongside various interbody fusion devices. Cervical procedure solutions include the CervAlign ACP anterior cervical plate system, the Fortilink-C IBF system utilizing TETRAfuse 3D technology for cervical interbody fusion, and the Streamline OCT system for occipito-cervico-thoracic posterior spine applications. The company also provides motion preservation systems, such as the Coflex Interlaminar Stabilization device for moderate to severe lumbar spinal stenosis in conjunction with decompression, the HPS 2.0 Universal Fixation system for posterior stabilization of the thoracolumbar spine, and the SImmetry SI Joint Fusion system, a minimally invasive implant designed to decrease opioid reliance, discomfort, and functional impairment. Furthermore, Surgalign is developing an innovative digital surgery platform that incorporates Augmented Reality and Artificial Intelligence specifically for spinal procedures. Products are sold to hospitals, ambulatory surgery centers, and healthcare providers via both independent spine and biomaterial distributors and a direct sales team. Established in 1997, the company is headquartered in Deerfield, Illinois.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Surgalign Holdings, Inc. (SRGA)
Surgalign Holdings, Inc. is a global medical technology firm dedicated to the design, production, distribution, and marketing of spinal implants. Its comprehensive product line addresses various spinal procedures: for thoracolumbar surgeries, it offers systems like the Streamline TL Spinal Fixation for complex and degenerative conditions, and the Streamline MIS Spinal Fixation for minimally invasive approaches, alongside various interbody fusion devices. Cervical procedure solutions include the CervAlign ACP anterior cervical plate system, the Fortilink-C IBF system utilizing TETRAfuse 3D technology for cervical interbody fusion, and the Streamline OCT system for occipito-cervico-thoracic posterior spine applications. The company also provides motion preservation systems, such as the Coflex Interlaminar Stabilization device for moderate to severe lumbar spinal stenosis in conjunction with decompression, the HPS 2.0 Universal Fixation system for posterior stabilization of the thoracolumbar spine, and the SImmetry SI Joint Fusion system, a minimally invasive implant designed to decrease opioid reliance, discomfort, and functional impairment. Furthermore, Surgalign is developing an innovative digital surgery platform that incorporates Augmented Reality and Artificial Intelligence specifically for spinal procedures. Products are sold to hospitals, ambulatory surgery centers, and healthcare providers via both independent spine and biomaterial distributors and a direct sales team. Established in 1997, the company is headquartered in Deerfield, Illinois.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free